Recon: FDA approves ImmunityBio bladder cancer treatment; Lawsuit alleges Novartis promoted asthma drug for preterm labor despite brain risk
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States